Training programme: Drug Discovery and Development
The programme offers the participants in-depth knowledge in drug discovery and development processes, and understranding on procedures applied in drug regulatory science and the role of drug regulatory authorities during the life-span of a drug.
For whom?
The programme is targeted to experts working in the field of drug development, pharmaceutical industry, biotechnology, contract research organisations (CRO) or regulatory authorities.
Duration and delivery
The programme scope is equivalent to 6 months full-time study. The scheduling of the studies is flexible.
Programme is delivered online and on-site in customer’s location or in Finland.
Learning outcomes
Participants learn to understand:
- up-to-date methods applied to identify and validate new drug targets, and to generate lead drug molecules
- technological innovations made in lead optimisation process
- how new drug candidates are investigated during the non-clinical drug development phase
- methods of clinical drug research, clinical drug development phases, clinical trial design and biostatistical study planning
- various aspects of the drug regulatory science and pharmacovigilance.
Contents of the programme
The Programme consists of four Academic Modules.
- Drug regulatory science
- Bioinformatics in drug discovery
- Computer-aided drug design
- Clinical trial design and clinical drug development
